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A B S T R A C T
The overall decrease in proteolytic activity in aging can promote and accelerate protein accumulation and
metabolic disturbances. To speciﬁcally analyze changes in macroautophagy (MA) we quantiﬁed diﬀerent
autophagy-related proteins (ATGs) in young, adult and old murine tissue as well as in young and senescent
human ﬁbroblasts. Thus, we revealed signiﬁcantly reduced levels of ATG5-ATG12, LC3-II/LC3-I ratio, Beclin-1
and p62 in old brain tissue and senescent human ﬁbroblasts. To investigate the role of mTOR, the protein itself
and its target proteins p70S6 kinase and 4E-BP1 were quantiﬁed. Signiﬁcant increased mTOR protein levels
were determined in old tissue and cells. Determination of phosphorylated and basal amount of both proteins
suggested higher mTOR activity in old murine tissue and senescent human ﬁbroblasts. Besides the reduced
levels of ATGs, mTOR can additionally reduce MA, promoting further acceleration of protein accumulation and
metabolic disturbances during aging.
1. Introduction
Dysfunction of regular protein turnover in aging can promote the
accumulation of oxidized, cross-linked and modiﬁed proteins, resulting
in protein aggregates which are involved in many age-related diseases
[1–3]. Besides the Ubiquitin-Proteasome-System (UPS), cells possess
the Autophagy-Lysosome pathway (ALP) (reviewed in [4]), responsible
for the degradation of long-lived proteins, cell organelles as well as
speciﬁcally sequestered cytoplasmic cargo [5,6]. To maintain the
autophagic delivery of cell constituents into the lysosomes, three
diﬀerent types of autophagy are available: chaperone-mediated autop-
hagy (CMA)[7], delivering soluble cytosolic proteins, microautophagy
and macroautophagy (MA). The initiation of MA is given by the
formation of a de novo- membrane which further maturates into a
double-membrane vesicle, the autophagosome. During selective MA
speciﬁcally ubiquitinated cargo (linked to K-63 polyubiquintin chains)
is delivered to the autophagosomal membrane by proteins such as p62
[5]. The initiation of autophagosome formation is a very well-regulated
conjunction, among others carried out by Beclin-1-VPS34 and mam-
malian target of rapamycin complex I (mTORC1) [8]. Particularly MA
has been reported to be inhibited by mTORC1 (referred to as mTOR
from here on) [9]. Besides the inhibition of autophagosome initiation,
it has also been suggested that mTOR directly acts on ATGs by
regulating phosphatase PP2A [10]. Thus, diﬀerent ATG markers can
be used for monitoring autophagy (reviewed in [11]). One important
protein is Beclin-1, mainly responsible for autophagosome assembly
and the recruitment of other ATGs [12]. For instance, ATG5-ATG12/
ATG16 belongs to those ATGs which are necessary for the early
autophagosome formation. Additionally, the complex is also important
for LC3-II conversion [13,14], one of the commonly used autophagy
protein markers. To estimate the autophagic ﬂux, the formation of the
unbound LC3-I into the membrane-bound LC3-II can be determined.
Another important protein to follow the protein delivery by autophagy
is p62/SQSTM1 (p62). In general, since autophagy is a highly dynamic
process; it has to be clearly distinguished between an impaired
degradation and a decreased autophagic ﬂux.
To monitor the changes in MA during aging, this study will compare
MA by analyzing diﬀerent ATGs in young, adult and old murine brain
tissue as well as in senescent human ﬁbroblasts. To verify the
functionality of MA, quantiﬁcation of ferritin H as a substrate for the
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ALP will be performed additionally. Finally, the role of mTOR on MA in
both “aging models” will be examined, quantifying mTOR and analyz-
ing its target proteins p70S6K (Thr389) and 4E-BP1 (Thr37/Thr46).
2. Materials and methods
2.1. Cell culture
Cell culture materials were received from Biochrom and all other
chemicals were purchased from Sigma-Aldrich. Human dermal ﬁbro-
blasts were obtained from human foreskin tissue of a 1-year old donor,
kindly provided by Prof. Scharﬀetter-Kochanek from the University of
Ulm, Germany. Cells were grown in DMEM (10% fetal bovine serum
(FBS) and 1% L-glutamine) and were kept in 5% CO2 at 37 °C and 95%
humidity. Cells were passaged once a week or when reaching 85%
conﬂuency. Fibroblasts with 60 population doublings (PD) were
deﬁned as “old, senescent” cells, up to 20 as “young cells”. Inhibition
of lysosomal activity was performed using Concanamycin A (ConA,
Sigma-Aldrich, C9705) at a ﬁnal concentration of 250 nM.
2.2. Mice
C57/BL/6 J male mice were housed in polycarbonate cages,
received standard diet and were kept under standard light-dark cycles.
Mice were sacriﬁced by cervical dislocation at diﬀerent stages of age:
8–10 weeks (young), 6 months (adult) and 18–25 months (old). Brains
were immediately placed in liquid nitrogen and subsequently stored at
−80 °C for further analysis. For immunoblot analysis brain tissue was
homogenized by the Potter-Elvehjem homogenization method, using a
60 mM Imidazole/HCl lysis buﬀer pH 6.8. Protein concentrations were
determined by the Bradford assay (BioRad, 5000006) and immunoblot
analyses were performed as described below.
2.3. Immunoblot analysis
For protein quantiﬁcation, controls and treated cells were har-
vested, lysed and protein concentration was determined by Lowry assay
(BioRad, 5000111). Further, 20 µg protein lysate was added to
Laemmli buﬀer (0.25 M Tris (pH 6.8), 40% glycerol, 8% SDS, 0.03%
Orange G (Carl Roth, 0318.2) and loaded on a 12 or 15% acrylamide
gel SDS-PAGE (BioRad, Munich, Germany). Afterwards, proteins were
transferred to nitrocellulose (VWR, 10600002) and subsequently
blocked in Odyssey© blocking buﬀer (LI-COR Biosciences, 927-
40003) for 1 h at RT. Incubation with the primary antibodies was
carried out for 1 h and the following antibodies were used: rabbit
monoclonal ferritin H antibody (Cell signaling, 3998 S), rabbit and
mouse monoclonal GAPDH antibody (Abcam, ab8245, ab37168),
mouse monoclonal p62 antibody (Abcam, ab56416), rabbit monoclonal
Beclin-1 antibody (Cell signaling, 3738 S), mouse monoclonal ATG5-
7C6 antibody (speciﬁcally recognizes the ATG5-ATG12 protein com-
plex at 55 kDa, NanoTools 0262-100) and LC3 antibody (speciﬁcally
recognizes LC3-I at 18 kDa and LC3-II at 16 kDa (NanoTools, 0231-
Fig. 1. Examination of autophagy-associated proteins in young, adult and old C57BL/6J male mice. Panels depict immunoblot analyses of (A) p62, (B) ATG5-ATG12 and
(C) Beclin-1 in young, adult and old brain tissue from C57BL/6J male mice. Four lanes represent four individual mice per age group. All data were analyzed in relation to GAPDH and
the young control was set to 100%. Statistical signiﬁcant diﬀerences between young, adult and old tissue were calculated, using one-way ANOVA, followed by Tukey's post hoc test and
are shown by *p < 0.05, **p < 0.01, all compared to young control.
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100). For the determination of the mTOR pathway we used a mTOR
Substrate Antibody Sampler Kit (Cell signaling, #9862) and antibodies
against the basal substrate proteins p70S6 Kinase (Cell signaling,
2708 P) and 4E-BP1 (Cell signaling, 5492 S). Secondary antibodies
(all LI-COR Biosciences) were used according to the speciﬁcations of
the manufacturer and membranes were quantiﬁed with the Odyssey
Infrared Imaging System (LI-COR Biosciences). Blot quantiﬁcations
were performed using the Image Studio™ Software (LI-COR
Biosciences).
2.4. Immunohistochemical staining of ferritin H in young and old
murine brain tissue
Paraﬃn-embedded brain sections (4 µm) were stained and ana-
lyzed for ferritin H, using rabbit monoclonal ferritin H antibody (Cell
signaling, 3998 S) and the EnVision+ System-HRP (DAB) (Dako,
K4010) as well as haematoxylin–eosin to evaluate histology.
Representative images were generated with the MIRAX Digital Slide
Scanner from Zeiss and pictured with the MIRAX Viewer 1.2.
3. Results
3.1. Investigation of MA in young, adult and old murine brain tissue
To analyze potential diﬀerences in MA during aging, we analyzed
diﬀerent ATGs, such as p62, ATG5-ATG12 and Beclin-1 in young, adult
and old mice brain tissue (Fig. 1A-C). In total the quantiﬁcation shows
an overall decrease in all analyzed proteins with increasing age,
particularly for ATG5-ATG12 and Beclin-1 the values were strongly
reduced. To investigate a potential inﬂuence of mTOR, we also
quantiﬁed basal mTOR levels, obtaining signiﬁcantly increased protein
levels in the old murine brain samples (Fig. 2). To estimate the activity
of mTOR, we calculated the ratio of the phosphorylated to the basal
form of p70S6K and 4E-BP1 (Fig. 3A-F), indicating a strong presence
of mTOR activity in tissues of old mice. Additionally we also analyzed
ferritin H protein levels in all three aging conditions, since degradation
of this protein is largely dependent on functional MA. We performed
immunohistological analyses (IHC) (Fig. 4A) as well as immunoblot
analyses of the protein in young, adult and old murine brain tissue
(Fig. 4B). As one can see, in both cases ferritin H values are
signiﬁcantly higher in the old murine brain samples.
3.2. Protein expression of autophagy-related protein marker in
young and old ﬁbroblasts
To monitor the age-related changes in MA in cells, we analyzed the
relative protein expression of the ATGs p62, ATG5-ATG12 and Beclin-
1 in ﬁbroblasts (Fig. 5B-D). To further estimate the autophagic ﬂux, we
quantiﬁed the conversion of LC3-II by the ratio of LC3-II/LC3-I with
and without the lysosomal inhibitor Concanamycin A (ConA) (Fig. 5A).
We observed a statistical signiﬁcant increase of the LC3-II/LC3-I ratio
in the young controls (no ConA), compared to the young 24 h ConA
treated, which was 4-fold higher than this ratio in old cells. To analyze
the delivery of proteins to the lysosomes we quantiﬁed p62 (Fig. 5B),
obtaining signiﬁcant higher concentrations of the protein in young,
compared to the old cells. Comparing control cell p62 to cells treated
with ConA, higher values of p62, up to 25% in young cells compared to
old, were detected. Additionally, quantiﬁcation of ATG5-ATG12
(Fig. 5C) and Beclin-1 (Fig. 5D) showed signiﬁcantly decreased levels
of both proteins in old cells compared to the young. ConA incubation
had no further eﬀect on both protein levels.
3.3. Quantiﬁcation of mTOR and determination of its activity, using
p70S6K and 4E-BP1 in young and senescent ﬁbroblasts
To clarify a potential involvement of mTOR in downregulation of MA
during cellular senescence and to conﬁrm the data in the old murine tissue,
relative protein levels of mTOR, p70S6K and 4E-BP1 (Fig. 6A-G) were
quantiﬁed in young and senescent ﬁbroblasts. Immunoblot analyses of
mTOR showed signiﬁcantly higher protein levels in the old, compared to
the young cells. By determining the phosphorylated (Fig. 6A/D) and the
basal forms (Fig. 6B/E) of p70S6K and 4E-BP1, the ratios also suggested a
higher activity of mTOR in the old cells.
4. Discussion
To ensure cellular protein maintenance eukaryotic cells exert two
proteolytic quality control systems: the UPS and the ALP. During aging,
a progressive loss of cellular function and a decrease of turnover and
repair systems leads to an increase in modiﬁed and cross-linked
protein aggregates, such as lipofuscin [15,16] or advanced glycation
end products [17–19]. In cellular senescence, a decrease of 20S activity
was already reported by our group [1,20,21] and others [22,23] in
diﬀerent models. In order to obtain also more information about the
changes in MA during the aging process, we analyzed diﬀerent MA-
related proteins in young, adult and old murine brain tissue (Fig. 1A-
C). Particularly for complex ATG5-ATG12 and Beclin-1 the protein
levels are highly reduced in old tissue. Both proteins are responsible for
the early autophagosome formation. Previous studies have already
shown that knock-out of ATG5 led to an inevitably reduced transfer of
autophagy substrates into the lysosomes [16,24]. Moreover, it has been
previously described that ATG5 in complex with ATG12 is essential for
Fig. 2. Relative quantiﬁcation of mTOR protein levels in brain tissue of
young, adult and old C57BL/6J mice. To quantify mTOR protein levels samples
were prepared as described above (see methods) and all data were analyzed in relation to
GAPDH, setting the young control at 100%. Statistical signiﬁcant diﬀerences between
young, adult and old murine brain tissue samples were obtained, using one-way ANOVA,
followed by Tukey's post hoc test and are shown by **p < 0.01, all compared to young
control.
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the formation of autophagosomes [13,25]. Due to the capability of
ATG5 to bind to the autophagosomal membrane, it also transfers
ATG12 close to the membrane. The tethering activity of ATG12 further
enables LC3-I to get close to the phosphatidylethanolamine in the
autophagic membrane, necessary to form the LC3-II [14]. The results
for the ATG5-ATG12 complex showed a high decrease of protein levels
in old, compared to young murine brain tissue (Fig. 1B). Due to the fact
that ATG12, as well as Beclin-1, are assumed to be recycled by the
proteasome, the lysosomal inhibitor ConA showed no further eﬀect on
their protein expression levels (as demonstrated for the ﬁbroblasts in
Fig. 5C/D). Thus, both proteins account as good MA markers in tissue
samples without lysosomal inhibitor control [26,27]. Beclin-1 is also a
key component of the phosphatidylinositol 3-kinase class III
(PtdIns3KC3) complex, which regulates the initiation of autophago-
somes and enables the recruitment of other autophagy-related proteins
[12,28,29]. By immunoblot analysis we were able to show a signiﬁcant
Fig. 3. Determination of mTOR activity by p70S6K and 4E-BP1 in brain tissue of young, adult and old C57BL/6J mice. Panel (A) shows the amount of p-p70S6K, while
panel (B) demonstrates the basal amount of the protein in young, adult and old murine brain tissues from C57BL/6J male mice. The immunoblots are shown for four individual mice per
age group. In panel (C) the ratio of p-p70S6K to basal p70S6K is given. Panels (D-F) show the analysis of 4E-BP1. Panel (D) demonstrates the amount of the p-4E-BP1, followed by panel
(E), indicating the amount of the basal 4E-BP1 protein. The ratio of the p-4E-BP1 to 4E-BP1 is given in panel (F). All data were analyzed in relation to GAPDH and data are shown as
percentages in relation to the young control. Statistical signiﬁcant diﬀerences between young, adult and old murine brain samples were calculated, using one-way ANOVA, followed by
Tukey's post hoc test and are indicated by *p < 0.05 and **p < 0.01, all compared to young control..
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decrease of the steady state levels of Beclin-1 in the old tissue. To
further validate the autophagic delivery we also analyzed p62, having a
major part in this process (reviewed in [30,31]). According to its
capability to act as a linker between ubiquitinated proteins and LC3-I,
it functions as an important “delivery” enzyme for speciﬁc autolysoso-
mal degradation [32]. Analyzing p62 we obtained a higher formation
rate of the protein in young, compared to old cells. Lower basal p62
level can be due to a reduced protein expression or increased
autophagy ﬂux, based on its incorporation into the complete autolyso-
somes. Thus, comparisons of control and ConA treated cells are
necessary to judge the autophagic ﬂux. Lower levels of p62 in old cells
reduce the transfer of proteins to the autophagic membrane and thus
slow down the degradation rate. Degradation of ferritin H by lysosomal
activities has been reported in diﬀerent studies. Besides ferritin H
turnover by the proteasome [33,34], the ALP seems to be mainly
responsible for the degradation of the protein [35–37], assuming
higher ferritin H levels when lysosomal activity is inhibited. Recent
studies have shown, that particularly macroautophagy is involved in
ferritin H removal [38,39]. Besides decreased levels of ATGs, increased
levels of ferritin H can further be indicative for a decline of MA in aged
tissues. Due to high ferritin H levels in the brain and an already
described increase in brain ferritin levels within aging [40,41] we
assumed that possibly impaired MA is responsible for elevated ferritin
H levels in aging. To clearly demonstrate impairment in MA we
additionally quantiﬁed ferritin H, known to be removed by MA
[38,39]. The analyzed ferritin H levels by IHC and immunoblot
analyses clearly demonstrated a consistent rise of the protein levels
with increasing age, resulting in signiﬁcantly higher ferritin H levels in
brain homogenates of old mice, compared to the young ones (Fig. 4).
To conﬁrm that our results in murine tissue are not the result of
changes in brain cell composition or other factors then aging, we also
repeated the experiments in young and senescent ﬁbroblasts, a
senescence model already described and published by Jung et al.
[42]. The use of these ﬁbroblasts also enables us to compare the MA-
related proteins also to a lysosomal inhibitor control, providing better
monitoring of the autophagic ﬂux. For inhibition of the lysosomal
activity, we used the lysosomal inhibitor ConA, which is able to block
the acidiﬁcation of the lysosomes by inhibiting the membrane-bound
V-ATPases [16,43]. Thus, we analyzed p62, ATG5-ATG12 and Beclin-
1in the young and old ﬁbroblast (Fig. 5B-D) and were able to conﬁrm a
signiﬁcant decrease in all MA-related marker proteins in the old cells,
compared to the respective ConA control. In addition we also examined
the conversion of LC3-I into LC3-II. Regarding LC3 it is widely
accepted that LC3-II conversion can be used as a reliable marker of
autophagosome formation under the consideration of certain para-
meters (reviewed in [11,27]). Since LC3-II can also be degraded by the
ALP, a comparison to a sample treated with a lysosomal inhibitor, such
as ConA, is required, explaining why we were unable to quantify the
protein in murine tissue samples. Without comparison to a lysosomal
inhibitor, conclusion whether the content of LC3-II results from an
increased expression or an enhanced accumulation of the protein itself
is not possible [44]. Old cells can also have higher basal LC3-II levels
due to impairment in the further pathway. But our results clearly
demonstrate a signiﬁcant reduced formation rate of LC3-II in old cells,
compared to young ﬁbroblasts (Fig. 5A). To further investigate whether
mTOR plays a role in the age-related reduction of MA, we additionally
analyzed its protein and activity levels. Immunoblot analyses of mTOR
clearly showed a signiﬁcant increase in protein levels in both, old
murine brain tissue (Fig. 2) and old ﬁbroblasts (Fig. 6G). To demon-
strate whether the enzyme is also more active, we additionally analyzed
p70S6K and 4E-BP1, both well-known to be phosphorylated by the
rapamycin aﬀected mTORC1, particularly known to impair autophagy
[45,46]. The more phosphorylated these proteins are, the more active is
mTOR. To correctly estimate the results, the ratio of the phosphory-
lated to the basal form of the respective proteins has to be calculated,
since a decrease in target phosphorylation seems not to be accompa-
nied by a decrease in mTOR activity. Possibly, the result can also be
aﬀected by lower basal levels of the proteins themselves. By determin-
ing the phosphorylated and the basal amounts of both substrates, we
were able to show a higher phosphorylation rate (Figs. 3 and 6),
suggesting a still high mTOR activity in old tissue and old ﬁbroblasts.
In combination with the results for the mTOR quantity we concluded
that mTOR might also play a decisive role, together with a distinct
decrease of all analyzed ATGs, in age-related deregulation of autop-
hagy, causing the higher ferritin H levels in the old tissue.
In summary, our results emphasize that MA is reduced in old murine
brain tissue and in senescent human ﬁbroblasts. Diﬀerences in ATGs
between young and old tissue and cells, conﬁrmed our assumption that the
MA processes might be declined. An impairment of MA can also be
assumed by the higher basal ferritin H levels in the old tissue, known to be
mainly removed by the ALP. Furthermore, protein expression and activity
analyses of mTOR revealed a still high activity of the enzyme, which can
additionally promote the impairment of MA in old tissue and cells. Further
elucidating the pathway of MA to show how mTOR inﬂuences autophago-
some initiation or whether changes in transcription factors, such as STAT3,
might be responsible for the lesser expression of ATGs in aging, would be
interesting approaches for further studies on impaired proteolysis and
protein accumulation in aging and age-related disease.
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Fig. 4. Steady state levels of ferritin H in brain tissue of young, adult and old
C57BL/6J mice. In panel (A) representative immunohistochemistry of the distribution
of ferritin H in young and old murine brain sections is shown. Panel (B) displays the
protein expression of ferritin H in young, adult and old murine brain tissues from
C57BL/6J male mice. The immunoblots are shown for four individual mice per age
group. All data are protein levels in relation to GAPDH, setting the young control at
100%, statistical signiﬁcant diﬀerences between young, adult and old murine brain tissue
were calculated, using one-way ANOVA, followed by Tukey's post hoc test and are shown
by **p < 0.01, all compared to young control.
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Fig. 5. Examination of autophagy-associated proteins in young and old cells. Relative quantiﬁcation of ATGs were performed in young and old ﬁbroblasts with and without
24 h incubation of Concanamycin A (24 h ConA). Analyses were performed by immunoblotting in cell lysates (see methods), always comparing untreated and 24 h ConA treated samples.
Panels show: (A) quantiﬁcation of LC3-II/LC3-I ratio, (B) the amount of p62, (C) protein levels of ATG5-ATG12, (D) the amount of Beclin-1. All data were analyzed in relation to
GAPDH, setting the corresponding control young at 100%. Statistical signiﬁcant diﬀerences between controls and treated cells is shown by #p < 0.05, **p < 0.01, compared to the
corresponding control.
C. Ott et al. Redox Biology 10 (2016) 266–273
271
Funding
This work was funded by the German Research Foundation (DFG).
Acknowledgments
This study was supported by the German Research Foundation
(DFG).
References
[1] A. Hohn, J. Konig, T. Grune, Protein oxidation in aging and the removal of oxidized
proteins, J. Proteom. 92 (2013) 132–159.
[2] B. Friguet, Oxidized protein degradation and repair in ageing and oxidative stress,
FEBS Lett. 580 (2006) 2910–2916.
[3] C. Ott, T. Grune, Protein oxidation and proteolytic signalling in aging, Curr. Pharm.
Des. 20 (2014) 3040–3051.
[4] D.J. Klionsky, K. Abdelmohsen, A. Abe, M.J. Abedin, H. Abeliovich, A. Acevedo
Arozena, S.M. Zughaier, Guidelines for the use and interpretation of assays for
monitoring autophagy (3rd ed.), Autophagy 12 (2016) (1-222).
[5] V.I. Korolchuk, F.M. Menzies, D.C. Rubinsztein, Mechanisms of cross-talk between
the ubiquitin-proteasome and autophagy-lysosome systems, FEBS Lett. 584 (2010)
1393–1398.
[6] A. Hohn, T. Grune, Lipofuscin: formation, eﬀects and role of macroautophagy,
Redox Biol. 1 (2013) 140–144.
[7] A.M. Cuervo, E. Wong, Chaperone-mediated autophagy: roles in disease and aging,
Cell Res 24 (2014) 92–104.
[8] A.P. Moller, Y. Chabi, J.J. Cuervo, F. De Lope, J. Kilpimaa, M. Kose, J. von
Hirschheydt, An analysis of continent-wide patterns of sexual selection in a
passerine bird, Evolution 60 (2006) 856–868.
[9] Y. Cao, J.A. Espinola, E. Fossale, A.C. Massey, A.M. Cuervo, M.E. MacDonald,
S.L. Cotman, Autophagy is disrupted in a knock-in mouse model of juvenile
neuronal ceroid lipofuscinosis, J. Biol. Chem. 281 (2006) 20483–20493.
[10] C. Reid, M. Rushe, M. Jarpe, H. van Vlijmen, B. Dolinski, F. Qian, P.A. Boriack-
Sjodin, Structure activity relationships of monocyte chemoattractant proteins in
complex with a blocking antibody, Protein Eng. Des. Sel. 19 (2006) 317–324.
[11] A.C. Massey, S. Kaushik, G. Sovak, R. Kiﬃn, A.M. Cuervo, Consequences of the
selective blockage of chaperone-mediated autophagy, Proc. Natl. Acad. Sci. USA
103 (2006) 5805–5810.
[12] A.M. Cuervo, Autophagy in neurons: it is not all about food, Trends Mol. Med. 12
(2006) 461–464.
[13] J. Romanov, M. Walczak, I. Ibiricu, S. Schuchner, E. Ogris, C. Kraft, S. Martens,
Mechanism and functions of membrane binding by the Atg5-Atg12/Atg16 complex
Fig. 6. Determination of mTOR amount and its activity by p70S6K and 4E-BP1 in young and old human ﬁbroblasts. Panels show the levels of (A) phosphorylated p-
p70S6K and (B) basal p70S6K in young and old human ﬁbroblast. Panel (C) shows the calculated ratio of p-p70S6K to basal p70S6K. In panels (D-F), the analyses of the second target
protein 4E-BP1 is shown, while panel (D) shows the amount of the p-4E-BP1, panel (E) demonstrates the amount of the basal 4E-BP1 protein. The calculated ratio of p-4E-BP1 to 4E-
BP1 is given in panel (F). mTOR analysis is presented in panel G. All data were analyzed in relation to GAPDH and data are shown as percentages, setting the young cells at 100%.
Statistical signiﬁcant diﬀerences between control and treated cells were calculated, using Turkey's post hoc test, followed by Tukey's post hoc test and are shown by *** p < 0.001, all
compared to the young.
C. Ott et al. Redox Biology 10 (2016) 266–273
272
during autophagosome formation, EMBO J. 31 (2012) 4304–4317.
[14] S. Kaushik, A.C. Massey, A.M. Cuervo, Lysosome membrane lipid microdomains:
novel regulators of chaperone-mediated autophagy, EMBO J. 25 (2006)
3921–3933.
[15] A. Hohn, T. Jung, S. Grimm, T. Grune, Lipofuscin-bound iron is a major
intracellular source of oxidants: role in senescent cells, Free Radic. Biol. Med. 48
(2010) 1100–1108.
[16] A. Hohn, A. Sittig, T. Jung, S. Grimm, T. Grune, Lipofuscin is formed indepen-
dently of macroautophagy and lysosomal activity in stress-induced prematurely
senescent human ﬁbroblasts, Free Radic. Biol. Med. 53 (2012) 1760–1769.
[17] S. Grimm, C. Ott, M. Horlacher, D. Weber, A. Hohn, T. Grune, Advanced-glycation-
end-product-induced formation of immunoproteasomes: involvement of RAGE and
Jak2/STAT1, Biochem J. 448 (2012) 127–139.
[18] C. Ott, K. Jacobs, E. Haucke, A. Navarrete Santos, T. Grune, A. Simm, Role of
advanced glycation end products in cellular signaling, Redox Biol. 2 (2014)
411–429.
[19] A. Simm, C. Casselmann, A. Schubert, S. Hofmann, A. Reimann, R.E. Silber, Age
associated changes of Age-receptor expression: rage upregulation is associated with
human heart dysfunction, Exp. Gerontol. 39 (2004) 407–413.
[20] N. Sitte, M. Huber, T. Grune, A. Ladhoﬀ, W.D. Doecke, T. Von Zglinicki,
K.J. Davies, Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of
ﬁbroblasts, FASEB J. 14 (2000) 1490–1498.
[21] T. Grune, T. Jung, K. Merker, K.J. Davies, Decreased proteolysis caused by protein
aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during
oxidative stress, aging, and disease, Int J. Biochem Cell Biol. 36 (2004) 2519–2530.
[22] N. Chondrogianni, E.S. Gonos, Proteasome dysfunction in mammalian aging: steps
and factors involved, Exp. Gerontol. 40 (2005) 931–938.
[23] I. Petropoulos, M. Conconi, X. Wang, B. Hoenel, F. Bregegere, Y. Milner, B. Friguet,
Increase of oxidatively modiﬁed protein is associated with a decrease of proteasome
activity and content in aging epidermal cells, J. Gerontol. A Biol. Sci. Med. Sci. 55
(2000) B220–B227.
[24] K. Tashiro, M. Shishido, K. Fujimoto, Y. Hirota, K. Yo, T. Gomi, Y. Tanaka, Age-
related disruption of autophagy in dermal ﬁbroblasts modulates extracellular
matrix components, Biochem. Biophys. Res Commun. 443 (2013) 162–172.
[25] T. Hanada, N.N. Noda, Y. Satomi, Y. Ichimura, Y. Fujioka, T. Takao, Y. Ohsumi, The
Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in
autophagy, J. Biol. Chem. 282 (2007) 37298–37302.
[26] M.R. Cortez, A.P. Pinho, P. Cuervo, F. Alfaro, M. Solano, S.C. Xavier, A.M. Jansen,
Trypanosoma cruzi (Kinetoplastida Trypanosomatidae): ecology of the transmis-
sion cycle in the wild environment of the Andean valley of Cochabamba, Bolivia,
Exp. Parasitol. 114 (2006) 305–313.
[27] D.J. Klionsky, F.C. Abdalla, H. Abeliovich, R.T. Abraham, A. Acevedo-Arozena,
K. Adeli, B. Zuckerbraun, Guidelines for the use and interpretation of assays for
monitoring autophagy, Autophagy 8 (2012) 445–544.
[28] A.C. Massey, C. Zhang, A.M. Cuervo, Chaperone-mediated autophagy in aging and
disease, Curr. Top. Dev. Biol. 73 (2006) 205–235.
[29] S.L. Ratcliﬀ, A. Brown, L. Rosenberg, M. Rosenberg, R.S. Robert, L.J. Cuervo,
W.J. Meyer 3rd, The eﬀectiveness of a pain and anxiety protocol to treat the acute
pediatric burn patient, Burns 32 (2006) 554–562.
[30] Y. Ichimura, M. Komatsu, Selective degradation of p62 by autophagy, Semin
Immunopathol. 32 (2010) 431–436.
[31] D.J. Klionsky, K. Abdelmohsen, A. Abe, M.J. Abedin, H. Abeliovich, A. Acevedo
Arozena, S.M. Zughaier, Guidelines for the use and interpretation of assays for
monitoring autophagy (3rd edition), Autophagy 12 (2016) (1-222).
[32] M. Komatsu, Y. Ichimura, Physiological signiﬁcance of selective degradation of p62
by autophagy, FEBS Lett. 584 (2010) 1374–1378.
[33] I. De Domenico, M.B. Vaughn, L. Li, D. Bagley, G. Musci, D.M. Ward, J. Kaplan,
Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by
the proteasome, EMBO J. 25 (2006) 5396–5404.
[34] P. Voss, L. Horakova, M. Jakstadt, D. Kiekebusch, T. Grune, Ferritin oxidation and
proteasomal degradation: protection by antioxidants, Free Radic. Res 40 (2006)
673–683.
[35] T.Z. Kidane, E. Sauble, M.C. Linder, Release of iron from ferritin requires
lysosomal activity, Am. J. Physiol. Cell Physiol. 291 (2006) (C445-455).
[36] T. Asano, M. Komatsu, Y. Yamaguchi-Iwai, F. Ishikawa, N. Mizushima, K. Iwai,
Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-
replete cells, Mol. Cell Biol. 31 (2011) 2040–2052.
[37] D.C. Radisky, J. Kaplan, Iron in cytosolic ferritin can be recycled through lysosomal
degradation in human ﬁbroblasts (Pt 1)Biochem J. 336 (1998) 201–205.
[38] W. Hou, Y. Xie, X. Song, X. Sun, M.T. Lotze, H.J. Zeh 3rd, D. Tang, Autophagy
promotes ferroptosis by degradation of ferritin, Autophagy 12 (2016) 1425–1428.
[39] J.D. Mancias, X. Wang, S.P. Gygi, J.W. Harper, A.C. Kimmelman, Quantitative
proteomics identiﬁes NCOA4 as the cargo receptor mediating ferritinophagy,
Nature 509 (2014) 105–109.
[40] J.R. Connor, S.L. Menzies, S.M. Martin St, E.J. Mufson, Cellular distribution of
transferrin, ferritin, and iron in normal and aged human brains, J. Neurosci. Res 27
(1990) 595–611.
[41] J.R. Connor, B.S. Snyder, P. Arosio, D.A. Loeﬄer, P. LeWitt, A quantitative analysis
of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased
brains, J. Neurochem 65 (1995) 717–724.
[42] T. Jung, A. Hohn, B. Catalgol, T. Grune, Age-related diﬀerences in oxidative
protein-damage in young and senescent ﬁbroblasts, Arch. Biochem Biophys. 483
(2009) 127–135.
[43] J.A. Sobota, N. Back, B.A. Eipper, R.E. Mains, Inhibitors of the V0 subunit of the
vacuolar H+-ATPase prevent segregation of lysosomal- and secretory-pathway
proteins, J. Cell Sci. 122 (2009) 3542–3553.
[44] J.A. Diaz, C. Cuervo, A.M. Valderrama, J. Kohles, Valdecoxib provides eﬀective pain
relief following acute ankle sprain, J. Int. Med. Res. 34 (2006) 456–467.
[45] A.C. Massey, R. Kiﬃn, A.M. Cuervo, Autophagic defects in aging: looking for an
"emergency exit"?, Cell Cycle 5 (2006) 1292–1296.
[46] S. Giordano, V. Darley-Usmar, J. Zhang, Autophagy as an essential cellular
antioxidant pathway in neurodegenerative disease, Redox Biol. 2 (2014) 82–90.
C. Ott et al. Redox Biology 10 (2016) 266–273
273
